Dear Participants On behalf of the Organizing Committee as well as the Program Committee, we are pleased to invite you to the 2021 KoNECT-MOHW-MFDS International Conference, co-hosted by Ministry of Health and Welfare and Ministry of Food and Drug Safety.
As an one-of-a-kind conference on clinical trials in Asia, this year’s conference will be a hybrid event due to the unclear situation of future regulations in relation to the COVID-19 pandemic and in order to protect the health of the participants.
With our partnership, the three-day-long program will include workshops, plenary lectures, and sessions addressing the most relevant and applicable topics pertaining to new technologies and approaches in new medicine development including regulatory science, real-world studies, data-driven approaches, and patient-centric approaches in 3 parallel tracks. In particular, our sessions on advanced regenerative medicine, bio-pharmaceuticals and medical devices will allow for in-depth discussion on how to broaden patients’ access to new medicine.
We would like to thank all the members of the Conference Program Committee for their excellent work in ensuring the high quality of the conference program. My special thanks go to our MOHW and MFDS for advancing its mission of public health through this collaboration. We hope that your 2021 KoNECT-MOHW-MFDS International Conference Virtual Experience is not only stimulating, but also rewarding. We wish all the participants to enjoy the 7th KoNECT International Conference.
Byoungjun Bae, MPA, PhD
President of KoNECT
Organizing Committee Chair, 2021 KoNECT-MOHW-MFDS International Conference